Koss-Olinger Consulting’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-22,660	Closed	-$291K	–	243
2022 Q3	$291K	Buy	22,660 +3,752	+20%	+$48.2K	0.05%	157
2022 Q2	$133K	Buy	18,908 +3,824	+25%	+$26.9K	0.02%	170
2022 Q1	$125K	Buy	15,084 +4,664	+45%	+$38.7K	0.02%	189
2021 Q4	$71K	Buy	+10,420	New	+$71K	0.01%	208